Vulvar Vestibulitis: Clinical Trials

3 trials for Vulvar Vestibulitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 2, Completed 1
Phase 11Completed 1

Follow Vulvar Vestibulitis: new trials by email Literature Review of Vulvar Vestibulitis trials Research Report on Vulvar Vestibulitis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pregabalin for the Treatment of Vulvodynia
pregabalin - Vulvodynia, Vulvar Vestibulitis
Phase 2TerminatedThe Cleveland Clinic162009-02-012021-07-19
5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis
5% topical lidocaine ointment, Placebo cream - Vulvar Vestibulitis
Phase 2TerminatedUniversity of North Carolina, Chapel Hill142006-12-012012-07-16
Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis
capsaicin, Placebo - Interstitial Cystitis, Vulvar Diseases
Phase 1 / Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1391995-06-012025-05-04

Narrower conditions

Cystitis, Interstitial (1)  ·  Rare Diseases (1)  ·  Urogenital Diseases (1)  ·  Vulvar Diseases (1)  ·  Vulvodynia (1)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Vulvitis (3)  ·  Urogenital Diseases (2)  ·  Vulvar Diseases (2)  ·  Cystitis (1)  ·  Disease Attributes (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Urinary Bladder Diseases (1)  ·  Urologic Diseases (1)

Interventions

Capsaicin (1)  ·  Pregabalin (1)

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  The Cleveland Clinic (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (3)

Top investigators

Beri M Ridgeway, MD (1)  ·  Denniz Zolnoun, MD MPH (1)  ·  Hugh Flood (1)  ·  Jacqueline Rohl, MD (1)  ·  John Steege, MD (1)  ·  Matthew D Barber, MD, MHS (1)

NIH funding

R01DK049524 (1)